# Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

> **NCT05256342** · NA · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 17 (actual)

## Conditions studied

- Knee, Osteoarthritis (OA)
- Biomarkers for Prediction of OA Treatment Efficacy

## Interventions

- **DRUG:** Duloxetine 60mg
- **DRUG:** Etoricoxib 60 mg
- **DRUG:** omeprazol

## Key facts

- **NCT ID:** NCT05256342
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-30
- **Primary completion:** 2024-04-07
- **Final completion:** 2024-04-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05256342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05256342, "Biomarkers for Prediction of Analgesic Efficacy in Knee OA.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05256342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*